The JFL Life Sciences IPO has begun on 25 Aug 2022. It will close on 30 Aug 2022. The Total IPO Size is 18.17 Crore. The company set its IPO price is 61 Rs Per Share. Basically, there are two basic categories in JFL Life Sciences IPO Subscription 1) Non-Institutional Investors 2) Retail Individual Investors (RIIs).
JFL Life Sciences is engaged in the business of manufacturing of pharmaceutical products. Their product portfolio consists of Dry powder injections ( B-Lactam ), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
They export our products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The Company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for the manufacturing of a particular product. Few of our products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.
Click:- Join Telegram Group
Can we Subscribe JFL Life Sciences IPO?
In our view, May be.
|Latest News Update: JFL Life Sciences IPO Subscription Status Live|
JFL Life Sciences IPO Subscription Status( 30 Aug 2022 )
|Day 1 (times)||Day 2 (times)||Day 3 (times)||Day 4 (times)|